NHHS Depositi SEC - NorthStar Healthcare Income, Inc.- Relazione annuale, dichiarazione di delega, prospetto informativo

Statistiche di base

CIK

1503707

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to NorthStar Healthcare Income, Inc.

SEC Filings (Chronological Order)

Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.

June 9, 2025	15-12G	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-55190 NorthStar Healthcare Income, Inc. (Compound Merger Sub LLC
June 9, 2025	S-3DPOS	As filed with the Securities and Exchange Commission on June 9, 2025 S-3DPOS As filed with the Securities and Exchange Commission on June 9, 2025 Registration No.
June 9, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2025 NorthStar Healthcare UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2025 NorthStar Healthcare Income, Inc. (Compound Merger Sub LLC as successor by merger to NorthStar Healthcare Income, Inc.) (Exact name of registrant as specified in its char
June 4, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2025 NorthStar Healthcare I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2025 NorthStar Healthcare Income, Inc.
May 23, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) o Defin
May 23, 2025	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2025 NorthStar Healthcare I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2025 NorthStar Healthcare Income, Inc.
May 8, 2025	EX-10.1	Gross-Up Agreement, dated as of January 29, 2025, by and between NorthStar Healthcare Income, Inc. and Kendall Young Exhibit 10.1 GROSS-UP AGREEMENT THIS GROSS-UP AGREEMENT (this “Agreement”) is made as of January 29, 2025 (the “Effective Date”), by and between NorthStar Healthcare Income, Inc., a Maryland corporation (together with its successors, including, without limitation, Merger Sub (as defined below) after the consummation of the Transactions (as defined below), the “Company” and together with its subsid
May 8, 2025	EX-10.2	Gross-Up Agreement, dated as of January 29, 2025, by and between NorthStar Healthcare Income, Inc. and Ann Harrington Exhibit 10.2 GROSS-UP AGREEMENT THIS GROSS-UP AGREEMENT (this “Agreement”) is made as of January 29, 2025 (the “Effective Date”), by and between NorthStar Healthcare Income, Inc., a Maryland corporation (together with its successors, including, without limitation, Merger Sub (as defined below) after the consummation of the Transactions (as defined below), the “Company” and together with its subsid
May 8, 2025	EX-10.3	Best-Net Cut-Back Agreement, dated as of January 29, 2025, by and between NorthStar Healthcare Income, Inc. and Nicholas Balzo Exhibit 10.3 BEST-NET CUT-BACK AGREEMENT THIS BEST-NET CUT-BACK AGREEMENT (this “Agreement”) is made as of January 29, 2025 (the “Effective Date”), by and between NorthStar Healthcare Income, Inc., a Maryland corporation (together with its successors, including, without limitation, Merger Sub (as defined below) after the consummation of the Transactions (as defined below), the “Company” and togeth
May 8, 2025	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regis
March 21, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) o Defin
March 18, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) o Defin
March 18, 2025	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 NorthStar Healthcare Income, Inc.
March 18, 2025	DEFM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) x Defin
March 14, 2025	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Subsidiaries Formation Entity Name Jurisdiction Aqua Operations NT-HCI, LLC Delaware Aqua Property NT-HCI, LLC Delaware Watermark Aqua Owner, LLC Delaware Watermark Aqua Operator, LLC Delaware Watermark Pinebrook, LLC Delaware Watermark Pinebrook Owner, LLC Delaware Watermark Pinebrook AP, LLC Delaware Watermark Pinebrook MC, LLC Delaware Wate
March 14, 2025	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
March 14, 2025	EX-19	Insider Trading Policy Exhibit 19 NORTHSTAR HEALTHCARE INCOME, INC. Insider Trading Policy Statement March 2025 It is the policy of NorthStar Healthcare Income, Inc. (the “Company”) that no director, officer, other employee, agent or representative of the Company or its subsidiaries or affiliates who is aware of material nonpublic information relating to the Company may, directly or through family members or other perso
March 7, 2025	PREM14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) o Defin
March 7, 2025	EX-FILING FEES	Calculation of Filing Fee Tables SCHEDULE 14A (Form Type) NORTHSTAR HEALTHCARE INCOME, INC. (Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation Exhibit 107 Calculation of Filing Fee Tables SCHEDULE 14A (Form Type) NORTHSTAR HEALTHCARE INCOME, INC.
February 4, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) o Defin
January 30, 2025	EX-2.1	, 2025, by and among the Company, Parent, Merger Sub and Guarantor Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER AMONG COMPOUND HOLDCO LLC, COMPOUND MERGER SUB LLC, NORTHSTAR HEALTHCARE INCOME, INC. AND WELLTOWER OP LLC DATED AS OF JANUARY 29, 2025 ARTICLE 1 DEFINITIONS 2 Section 1.1 Definitions. 2 Section 1.2 Interpretation and Rules of Construction 16 ARTICLE 2 THE MERGER 17 Section 2.1 The Merger 17 Section 2.2 Closing 17 Section 2.3 Effective Tim
January 30, 2025	EX-2.1	, 2025, by and among the Company, Parent, Merger Sub and Guarantor Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER AMONG COMPOUND HOLDCO LLC, COMPOUND MERGER SUB LLC, NORTHSTAR HEALTHCARE INCOME, INC. AND WELLTOWER OP LLC DATED AS OF JANUARY 29, 2025 ARTICLE 1 DEFINITIONS 2 Section 1.1 Definitions. 2 Section 1.2 Interpretation and Rules of Construction 16 ARTICLE 2 THE MERGER 17 Section 2.1 The Merger 17 Section 2.2 Closing 17 Section 2.3 Effective Tim
January 30, 2025	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2025 NorthStar Healthca UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2025 NorthStar Healthcare Income, Inc.
January 30, 2025	EX-99.1	release announcing the Merger Agreement, issued by the Company Exhibit 99.1 NorthStar Healthcare Income, Inc. to be Acquired by an affiliate of Welltower for $3.03 Per Share in a $900 Million Transaction TOLEDO, Ohio and KANSAS CITY, Missouri, January 29, 2025 /PRNewswire/ - Welltower® Inc (NYSE: WELL) (“Welltower”) and NorthStar Healthcare Income, Inc. (“NorthStar Healthcare”), an internally managed, public, non-listed real estate investment trust (REIT) tha
January 30, 2025	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2025 NorthStar Healthcare Income, Inc.
January 30, 2025	EX-99.1	NorthStar Healthcare Income, Inc. to be Acquired by an affiliate of Welltower for $3.03 Per Share in a $900 Million Transaction Exhibit 99.1 NorthStar Healthcare Income, Inc. to be Acquired by an affiliate of Welltower for $3.03 Per Share in a $900 Million Transaction TOLEDO, Ohio and KANSAS CITY, Missouri, January 29, 2025 /PRNewswire/ - Welltower® Inc (NYSE: WELL) (“Welltower”) and NorthStar Healthcare Income, Inc. (“NorthStar Healthcare”), an internally managed, public, non-listed real estate investment trust (REIT) tha
December 13, 2024	SC TO-T/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 2) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Su UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 2) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Company (Issuer)) COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP COMRIT INVESTMENTS LTD. (Bidders) COMMON STOCK, $0.01 PAR VALUE PER SHARE (Title of
November 26, 2024	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2024 NorthStar Healthcare Income, Inc.
November 8, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of R
November 8, 2024	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2024 NorthStar Healthcare Income, Inc.
October 28, 2024	SC TO-T/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Su UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Company (Issuer)) COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP COMRIT INVESTMENTS LTD. (Offerors) (Names of Filing Persons) COMMON STOCK, $0.01 PAR
October 24, 2024	10-K/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-
October 24, 2024	CORRESP	Management’s Report on Internal Control Over Financial Reporting 575 Lexington Avenue, 14TH Floor, New York, NY 10022 P 877.940.8777 \| F 303.648.5142 \| NorthStarHealthcareREIT.com October 24, 2024 VIA OVERNIGHT DELIVERY Mr. Jeffery Lewis U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: NorthStar Healthcare Income, Inc. Form 10-K for the fiscal year ended December 31, 2023 Form 10-Q for the quarter
October 17, 2024	EX-99.(A)(1)	October 17, 2024 Exhibit (a)(1) 575 Lexington Avenue, 14TH Floor, New York, NY 10022 P 877.940.8777 \| F 303.648.5142 \| NorthStarHealthcareREIT.com October 17, 2024 Dear Stockholder: We are writing to you on behalf of the board of directors (the “Board”) of NorthStar Healthcare Income, Inc. (“NorthStar Healthcare”) about an unsolicited tender offer being made for your shares of NorthStar Healthcare’s common stock b
October 17, 2024	SC 14D9	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 NorthStar Healthcare Income, Inc. (Name of Subject Company) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 NorthStar Healthcare Income, Inc.
October 17, 2024	8-K	Regulation FD Disclosure, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2024 NorthStar Healthcare Income, Inc.
October 15, 2024	EX-FILING FEES	Calculation of Filing Fee Table EX-FILING FEES Calculation of Filing Fee Tables Schedule TO (Rule 14d-100) NORTHSTAR HEALTHCARE INCOME, INC.
October 15, 2024	SC TO-T	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (RULE 14D-100) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Com SC TO-T 1 tm2425988d1sctot.htm SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (RULE 14D-100) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Company) COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP COMRIT INVESTMENTS LTD. (Offerors) (Names of Filing Persons) CO
October 15, 2024	EX-99.(A)(2)	Assignment Form Exhibit (a)(2) Assignment Form Please complete this form and send it back to us in the pre-addressed envelope.
October 15, 2024	EX-99.(A)(4)	Summary Advertisement Exhibit (a)(4) This announcement is neither an offer to buy nor a solicitation of an offer to sell securities.
October 15, 2024	EX-99.(A)(3)	Letter to Shareholders Exhibit (a)(3) October 15, 2024 RE: Liquidation Opportunity for NorthStar Healthcare Income, Inc.
October 15, 2024	EX-99.(A)(1)	Offer to Purchase Exhibit (a)(1) OFFER TO PURCHASE FOR CASH 3,000,000 SHARES OF COMMON STOCK OF NORTHSTAR HEALTHCARE INCOME, INC.
September 20, 2024	EX-99.1	NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Index Page Summary of Unaudited Pro Forma Consolidated Financial Statements 2 Unaudited Pro Forma Consolidated Balance Sheet as of June 30, 2024 3 Unaudited Pro Forma Consolidated Statement of Operations for the Six Months Ended June 30, 2024 4 Unaudited Pro Forma Consolid
September 20, 2024	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 20, 2024 NorthStar Healthcare Income, Inc.
August 12, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regist
August 12, 2024	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2024 NorthStar Healthcare Income, Inc.
June 25, 2024	SC TO-T/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Su UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Company (Issuer)) COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP COMRIT INVESTMENTS LTD. (Bidders) COMMON STOCK, $0.01 PAR VALUE PER SHARE (Title of
June 24, 2024	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2024 NorthStar Healthcare Income, Inc.
May 9, 2024	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 9, 2024 NorthStar Healthcare Income, Inc.
May 9, 2024	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regis
May 1, 2024	SC 14D9	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 NorthStar Healthcare Income, Inc. (Name of Subject Company) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 NorthStar Healthcare Income, Inc.
May 1, 2024	EX-99.(A)(1)	Letter to Stockholders, dated Exhibit (a)(1) 575 Lexington Avenue, 14TH Floor, New York, NY 10022 P 877.940.8777 \| F 303.648.5142 \| NorthStarHealthcareREIT.com May 1, 2024 Dear Stockholder: We are writing to you on behalf of the board of directors (the “Board”) of NorthStar Healthcare Income, Inc. (“NorthStar Healthcare”) about an unsolicited tender offer being made for your shares of NorthStar Healthcare’s common stock by Com
April 26, 2024	EX-99.(A)(4)	Summary Advertisement Exhibit (a)(4) This announcement is neither an offer to buy nor a solicitation of an offer to sell securities.
April 26, 2024	EX-99.(A)(1)	Offer to Purchase Exhibit (a)(1) OFFER TO PURCHASE FOR CASH 4,022,988 SHARES OF COMMON STOCK OF NORTHSTAR HEALTHCARE INCOME, INC.
April 26, 2024	EX-99.(A)(3)	Letter to Shareholders Exhibit (a)(3) April 26, 2024 RE: Liquidation Opportunity for NorthStar Healthcare Income, Inc.
April 26, 2024	SC TO-T	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (RULE 14D-100) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Com UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (RULE 14D-100) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Company) COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP COMRIT INVESTMENTS LTD. (Offerors) (Names of Filing Persons) COMMON STOCK, $0.01 PAR VALUE (Title of C
April 26, 2024	EX-FILING FEES	Calculation of Filing Fee Table EX-FILING FEES Calculation of Filing Fee Tables Schedule TO (Rule 14d-100) NORTHSTAR HEALTHCARE INCOME, INC.
April 26, 2024	EX-99.(A)(2)	Assignment Form Exhibit (a)(2) Assignment Form Please complete this form and send it back to us in the pre-addressed envelope.
April 15, 2024	EX-1	Joint Filing Agreement, dated as of April 15, 2024, by and between Comrit Investments Ltd., Comrit Investments 1, Limited Partnership, and Ziv Sapir, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. EX-1 2 tm2411764d1ex1.htm EXHIBIT 1 Exhibit 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) The undersigned acknowledge and agree that the foregoing statement on Amendment No. 1 to Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Amendment No. 1 to Schedule 13G shall be filed on behalf of each of the undersigned without the ne
April 15, 2024	DEFA14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) o Defin
April 15, 2024	SC 13G/A	NHHS / NorthStar Healthcare Income, Inc. / Comrit Investments 1, LP - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Amendment No. 1 Under the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) None or unknown (CUSIP Number) April 15, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the
April 15, 2024	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) x Defin
March 22, 2024	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Subsidiaries Formation Entity Name Jurisdiction Aqua Operations NT-HCI, LLC Delaware Aqua Property NT-HCI, LLC Delaware Bohemia NT-HCI, LLC Delaware Domino Holdings NT-HCI, LLC Delaware Eclipse Health Holdings NT-HCI, LLC Delaware Hauppauge NT-HCI, LLC Delaware Healthcare GA Holdings NT-HCI, LLC Delaware Islandia NT-HCI, LLC Delaware NHI Water
March 22, 2024	EX-10.9	First Amended and Restated Limited Liability Company Agreement of Trilogy REIT Holdings, LLC, dated as of September 11, 2015, by and between GACH3 Trilogy JV, LLC and Trilogy Holdings NT-HCI, LLC Exhibit 10.9 FIRST AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF TRILOGY REIT HOLDINGS, LLC (A Delaware limited liability company) Dated as of October 1, 2018 The membership interests evidenced hereby have not been registered with the Securities and Exchange Commission under the Securities Act (as defined herein) in reliance upon an exemption from registration thereunder and have not
March 22, 2024	EX-99.1	Trilogy REIT Holdings, LLC Consolidated Financial Statements as of December 31, 2023 (Unaudited) and 2022 EXHIBIT 99.1 Trilogy REIT Holdings, LLC Consolidated Financial Statements As of December 31, 2023 (Unaudited) and 2022 (Audited) and For the Years Ended December 31, 2023 (Unaudited), 2022 (Audited) and December 31, 2021 (Unaudited) 1 Trilogy REIT Holdings, LLC Consolidated Financial Statements December 31, 2023 (Unaudited), 2022 (Audited) and 2021 (Unaudited) Contents Independent Auditor’s Report
March 22, 2024	EX-97	Policy on Recovery of Erroneously Awarded Incentive-Based Compensation Exhibit 97 NORTHSTAR HEALTHCARE INCOME, INC. COMPENSATION RECOUPMENT POLICY Defined Terms For purpose of this policy, the following terms have the following meanings: “Company” means NorthStar Healthcare Income, Inc. “Compensation Committee” means the Compensation Committee of the Board of Directors of the Company. “Covered Executive” means any Executive Officer of the Company. “Effective Date” me
March 22, 2024	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2024 NorthStar Healthcare Income, Inc.
March 22, 2024	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
March 12, 2024	SC 13G	NHHS / NorthStar Healthcare Income, Inc. / Comrit Investments 1, LP - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securities) None or unknown (CUSIP Number) March 6, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to
March 12, 2024	EX-1	Joint Filing Agreement, dated as of March 12, 2024, by and between Comrit Investments Ltd., Comrit Investments 1, Limited Partnership, and Ziv Sapir, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended. Exhibit 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements.
March 11, 2024	SC TO-T/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Su UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Amendment No. 1) Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Company (Issuer)) COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP COMRIT INVESTMENTS LTD. (Bidders) COMMON STOCK, $0.01 PAR VALUE PER SHARE (Title of
January 12, 2024	EX-99.(A)(1)	Letter to Stockholders, dated January 11, 2024 Exhibit (a)(1) 16 East 34TH Street, 18TH Floor, New York, NY 10016 P 877.940.8777 \| F 303.648.5142 \| NorthStarHealthcareREIT.com January 11, 2024 Dear Stockholder: We are writing to you on behalf of the board of directors (the “Board”) of NorthStar Healthcare Income, Inc. (“NorthStar Healthcare”) about an unsolicited tender offer being made for your shares of NorthStar Healthcare’s common stock by
January 12, 2024	SC 14D9	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 NorthStar Healthcare Income, Inc. (Name of Subject Company) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION STATEMENT PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 NorthStar Healthcare Income, Inc.
January 8, 2024	SC TO-T	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (RULE 14D-100) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Com UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (RULE 14D-100) Tender Offer Statement Under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 NORTHSTAR HEALTHCARE INCOME, INC. (Name of Subject Company) COMRIT INVESTMENTS 1, LIMITED PARTNERSHIP COMRIT INVESTMENTS LTD. (Offerors) (Names of Filing Persons) COMMON STOCK, $0.01 PAR VALUE (Title of C
January 8, 2024	EX-99.(A)(2)	Assignment Form Exhibit (a)(2) Assignment Form Please complete this form and send it back to us in the pre-addressed envelope.
January 8, 2024	EX-99.(A)(3)	Letter to Shareholders Exhibit (a)(3) January 8, 2024 RE: Liquidation Opportunity for NorthStar Healthcare Income, Inc.
January 8, 2024	EX-FILING FEES	Calculation of Filing Fee Table EX-FILING FEES Calculation of Filing Fee Tables Schedule TO (Rule 14d-100) NORTHSTAR HEALTHCARE INCOME, INC.
January 8, 2024	EX-99.(A)(4)	Summary Advertisement Exhibit (a)(4) This announcement is neither an offer to buy nor a solicitation of an offer to sell securities.
January 8, 2024	EX-99.(A)(1)	Offer to Purchase Exhibit (a)(1) OFFER TO PURCHASE FOR CASH 9,350,000 SHARES OF COMMON STOCK OF NORTHSTAR HEALTHCARE INCOME, INC.
November 14, 2023	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2023 NorthStar Healthcare Income, Inc.
November 13, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of R
November 7, 2023	EX-10.1	, 2023, by and among GAHC3 Trilogy JV, LLC, American Healthcare REIT, Inc., Trilogy Holdings NT-HCI, LLC and NorthStar Healthcare Income Operating Partnership, LP MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among GAHC3 Trilogy JV, LLC, American Healthcare REIT, Inc.
November 7, 2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2023 NorthStar Healthcare Income, Inc.
October 4, 2023	EX-10.1	Offer Letter, dated September 30, 2023, from NorthStar Healthcare Income, Inc. to Ann Harrington (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 4, 2023 and incorporated herein by reference) Exhibit 10.1 16 East 34TH Street, 18TH Floor, New York, NY 10016 P 877.940.8777 \| F 303.648.5142 \| NorthStarHealthcareREIT.com September 30, 2023 VIA EMAIL Ann Harrington Dear Ann: On behalf of NorthStar Healthcare Income, Inc. (the “Company”), the purpose of this employment letter is to confirm the terms of your offer of employment with the Company. The term of your employment will commence on Oc
October 4, 2023	EX-10.2	Restrictive Covenant Agreement, dated October 1, 2023, between NorthStar Healthcare Income, Inc. and Ann B. Harrington (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on October 4, 2023 and incorporated herein by reference) Exhibit 10.2 RESTRICTIVE COVENANT AGREEMENT As a condition of my becoming employed by, or continuing employment with, NorthStar Healthcare Income, Inc. (the “Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by the Company, I agree to the following: Section 1.Confidential Information. (a)Company Group Information. I ac
October 4, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2023 NorthStar Healthcar UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 1, 2023 NorthStar Healthcare Income, Inc.
August 14, 2023	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2023 NorthStar Healthcare Income, Inc.
August 14, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regist
June 22, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2023 NorthStar Healthcare UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2023 NorthStar Healthcare Income, Inc.
May 10, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 NorthStar Healthcare I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 NorthStar Healthcare Income, Inc.
May 10, 2023	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regis
April 21, 2023	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) x Defin
March 27, 2023	EX-10.15	First Amendment to Transition Services Agreement, dated March 22, 2023, by and among NorthStar Healthcare Income, Inc., NorthStar Healthcare Operating Partnership, LP and CNI NSHC Advisors, LLC Exhibit 10.15 FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT This FIRST AMENDMENT TO TRANSITION SERVICES AGREEMENT (this “Amendment”) is entered into as of March 22, 2023 (the “Effective Date”), by and between NorthStar Healthcare Income, Inc., a Maryland corporation (“NHI”), NorthStar Healthcare Income Operating Partnership, LP, a Delaware limited partnership (“NHI OP” and together with NHI, th
March 27, 2023	EX-99.1	, LLC Consolidated Financial Statements as of December 31, 2022 and 2021 (Unaudited) Exhibit 99.1 Trilogy REIT Holdings, LLC Consolidated Financial Statements As of December 31, 2022 and 2021 (Unaudited) and For the Years Ended December 31, 2022, 2021 (Unaudited) and 2020 (Unaudited) and Independent Auditor’s Report Trilogy REIT Holdings, LLC Consolidated Financial Statements December 31, 2022, 2021 (Unaudited) and 2020 (Unaudited) Contents Independent Auditor’s Report 1 Consolida
March 27, 2023	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Trilogy Holdings NT-HCI LLC Delaware Winterfell Healthcare Holdings NT-HCI, LLC Delaware Winterfell Healthcare Owner, LLC Delaware Healthcare GA Holdings NT-HCI, LLC Delaware Domino Holdings NT-HCI
March 27, 2023	EX-4.2	Description of Registrant’s Securities Exhibit 4.2 Description of Registrant’s Securities References herein to “company,” “we,” “us,” or “our” refer to NorthStar Healthcare Income, Inc., a Maryland corporation, and its subsidiaries unless the context specifically requires otherwise. The following is a summary of the material terms of shares of our common stock as set forth in our charter and is qualified in its entirety by reference to
March 27, 2023	EX-10.6	NorthStar Healthcare Income, Inc. Fifth Amended and Restated Independent Directors Compensation Plan (filed as Exhibit 10.6 to the Company's Annual Report on Form 10-K for the year ended December 31, 2022 and incorporated herein by reference) Exhibit 10.6 NORTHSTAR HEALTHCARE INCOME, INC. FIFTH AMENDED AND RESTATED INDEPENDENT DIRECTORS COMPENSATION PLAN ARTICLE 1 PURPOSE 1.1.PURPOSE. The purpose of the Plan is to attract, retain and compensate highly- qualified individuals who are not employees of NorthStar Healthcare Income, Inc. or any of its subsidiaries or affiliates for service as members of the Board by providing them with compe
March 27, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2023 NorthStar Healthcare UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2023 NorthStar Healthcare Income, Inc.
March 27, 2023	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
March 9, 2023	EX-10.1	Form of Long-Term Incentive Award Agreement (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K on March 9, 2022 and incorporated herein by reference Exhibit 10.1 LONG TERM INCENTIVE AWARD AGREEMENT GRANT TO: (Grantee) by NorthStar Healthcare Income, Inc. (the “Company”) of a long-term incentive award, with a target opportunity of $[] (the “Award”) as of [], 2023 (the “Grant Date”) The Award is being issued pursuant to and subject to the provisions of the NorthStar Healthcare Income, Inc. Amended and Restated Long Term Incentive Plan (the “Plan
March 9, 2023	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193 Date of Report (Date of earliest event reported): March 3, 2023 NorthStar Healthcare I UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193 Date of Report (Date of earliest event reported): March 3, 2023 NorthStar Healthcare Income, Inc.
November 10, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of R
November 10, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2022 NorthStar Healthcare Income, Inc.
October 21, 2022	EX-10.4	Restrictive Covenant Agreement, dated October 21, 2022, between NorthStar Healthcare Income, Inc. and Kendall Young (filed as Exhibit 10.4 to the Company’s Current Report on Form 8-K on October 21, 2022 and incorporated herein by reference) EXHIBIT 10.4 RESTRICTIVE COVENANT AGREEMENT As a condition of my becoming employed by, or continuing employment with, NorthStar Healthcare Income, Inc. (the ?Company?), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by the Company, I agree to the following: Section 1. Confidential Information. (a) Company Group Information. I
October 21, 2022	EX-10.3	Offer Letter, dated October 21, 2022, from NorthStar Healthcare Income, Inc. to Kendall Young (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K on October 21, 2022 and incorporated herein by reference) EXHIBIT 10.3 October 21, 2022 VIA EMAIL Kendall Young Dear Kendall: On behalf of NorthStar Healthcare Income, Inc. (the ?Company?), the purpose of this employment letter is to confirm the terms of your offer of employment with the Company in connection with the consummation of the transactions contemplated by that certain Termination Agreement, by and among the Company, NorthStar Healthcare Income
October 21, 2022	EX-99.1	2 EXHIBIT 99.1 NorthStar Healthcare REIT Internalizes Management New York, Oct. 21, 2022 /PRNewswire/ ? NorthStar Healthcare Income, Inc. (the ?Company?) announced today that it and its external advisor, CNI NSHC Advisors, LLC (the ?Advisor?), have entered into a definitive agreement (the ?Termination Agreement?) to terminate the advisory agreement between the Company and the Advisor (the ?Advisory
October 21, 2022	EX-10.2	, 2022, by and among NorthStar Healthcare Income, Inc., NorthStar Healthcare Operating Partnership, LP and CNI NSHC Advisors, LLC. EXHIBIT 10.2 EXECUTION VERSION TRANSITION SERVICES AGREEMENT This Transition Services Agreement (this ?Agreement?), dated as of October 21, 2022 (the ?Effective Date?), is by and between NorthStar Healthcare Income, Inc., a Maryland corporation (?NHI?), NorthStar Healthcare Income Operating Partnership, LP, a Delaware limited partnership (?NHI OP? and together with NHI, the ?NHI Parties?), and CNI
October 21, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 193 Date of Report (Date of earliest event reported): October 21, 2022 NorthStar Healthcare Income, Inc.
October 21, 2022	EX-10.7	Retention Award Letter, dated July 29, 2022, from NRF Holdco, LLC and NorthStar Healthcare Income, Inc. to Nicholas Balzo (filed as Exhibit 10.7 to the Company’s Current Report on Form 8-K on October 21, 2022 and incorporated herein by reference) EXHIBIT 10.7 RETENTION AWARD LETTER TO: Nicholas Balzo DATE: July 29, 2022 RE: Retention Award We are pleased to inform you that you have been selected to receive the Retention Benefits (defined below) in connection with your employment with NRF Holdco, LLC or an affiliated entity (as applicable, the ?Company?) and your services to NorthStar Healthcare Income, Inc. or any of its subsidiaries and a
October 21, 2022	EX-10.5	Offer Letter, dated October 21, 2022, from NorthStar Healthcare Income, Inc. to Nicholas Balzo (filed as Exhibit 10.5 to the Company’s Current Report on Form 8-K on October 21, 2022 and incorporated herein by reference) EXHIBIT 10.5 October 21, 2022 VIA EMAIL Nicholas Balzo Dear Nick: On behalf of NorthStar Healthcare Income, Inc. (the ?Company?), the purpose of this employment letter is to confirm the terms of your offer of employment with the Company in connection with the consummation of the transactions contemplated by that certain Termination Agreement, by and among the Company, NorthStar Healthcare Income O
October 21, 2022	EX-10.1	Termination Agreement, dated October 21, 2022, by and among NorthStar Healthcare Income, Inc., NorthStar Healthcare Operating Partnership, LP, CNI NSHC Advisors, LLC and NRF Holdco, LLC (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K on October 21, 2022 and incorporated herein by reference) EXHIBIT 10.1 EXECUTION VERSION TERMINATION AGREEMENT by and among NORTHSTAR HEALTHCARE INCOME, INC., NORTHSTAR HEALTHCARE INCOME OPERATING PARTNERSHIP, LP, CNI NSHC ADVISORS, LLC and NRF HOLDCO, LLC dated as of October 21, 2022 Table of Contents Page Article I TERMINATION OF ADVISORY AGREEMENT; CLOSING.......................................... 1 Section 1.01 Termination of the Advisory Agreement..
October 21, 2022	EX-10.6	Restrictive Covenant Agreement, dated October 21, 2022, between NorthStar Healthcare Income, Inc. and Nicholas Balzo (filed as Exhibit 10.6 to the Company’s Current Report on Form 8-K on October 21, 2022 and incorporated herein by reference) EX-10.6 7 cfoformofrestrictivecovena.htm EX-10.6 EXHIBIT 10.6 RESTRICTIVE COVENANT AGREEMENT As a condition of my becoming employed by, or continuing employment with, NorthStar Healthcare Income, Inc. (the “Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by the Company, I agree to the following: Section 1. Confidenti
August 12, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2022 NorthStar Healthcare Income, Inc.
August 12, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regist
August 4, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2022 NorthStar Healthcare Income, Inc.
June 22, 2022	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2022 NorthStar Healthcare Income, Inc.
May 13, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2022 NorthStar Healthcare Income, Inc.
May 13, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regis
April 22, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 20, 2022 NorthStar Healthcare Income, Inc.
April 20, 2022	DEF 14A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registran DEF 14A 1 nshi2022proxystatement.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission On
March 18, 2022	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2022 NorthStar Healthcare Income, Inc.
March 18, 2022	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Trilogy Holdings NT-HCI LLC Delaware Winterfell Healthcare Holdings NT-HCI, LLC Delaware Winterfell Healthcare Owner, LLC Delaware Healthcare GA Holdings NT-HCI, LLC Delaware
March 18, 2022	EX-10.17	Portfolio Acquisition Agreement, dated as of November 1, 2021, by and between Watermark Albemarle Owner, LLC, Watermark Boca Ciega Bay Owner, LLC, Watermark Crystal Lake Owner, LLC, Watermark Greenbriar Owner, LLC, Watermark La Cholla Owner, LLC, Watermark Millbrook Owner, LLC, Watermark RiverVue Owner, LLC, Watermark Washington House Owner, LLC, Fountains Bellevue Owner NT-HCI, LLC, Fountains Bronson Place Owner NT-HCI, LLC, Fountains Canterbury Owner NT-HCI, LLC, Fountains Carlotta Owner NT-HCI, LLC, Fountains Lake Pointe Woods Owner NT-HCI, LLC and Fountains Sea Bluffs Owner NT-HCI, LLC, and certain other subsidiaries named therein, and Welltower Inc., WELL Trevi Tenant LLC, WELL Trevi CCRC Tenant LLC and certain other subsidiaries named therein CERTAIN IDENTIFIED INFORMATION, MARKED BY [***], HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.
March 18, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
March 18, 2022	EX-10.12	Form of Restricted Stock Unit Award Certificate (filed as Exhibit 10.12 to the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and incorporated herein by reference) Exhibit 10.12 RESTRICTED STOCK UNIT AWARD CERTIFICATE Non-transferable GRANT TO (?Grantee?) by NorthStar Healthcare Income, Inc. (the ?Company?) of restricted stock units convertible, on a one-for-one basis, into shares of Stock (the ?Units?) pursuant to and subject to the provisions of the NorthStar Healthcare Income, Inc. Fourth Amended and Restated Independent Directors Compensation Plan (the ?
March 4, 2022	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2022 NorthStar Healthcare Income, Inc.
March 4, 2022	EX-10.1	Amendment No. 4 to Advisory Agreement dated as of February 28, 2022 by and among NorthStar Healthcare Income, Inc., NorthStar Healthcare Income Operating Partnership, LP, CNI NSHC Advisors, LLC, DigitalBridge Group, Inc. and NRF Holdco, LLC Exhibit 10.1 AMENDMENT NO. 4 TO ADVISORY AGREEMENT THIS AMENDMENT NO. 4 (this ?Amendment?) is made and entered into as of February 28, 2022, by and among NorthStar Healthcare Income, Inc., a Maryland corporation (the ?Company?), NorthStar Healthcare Income Operating Partnership, LP, a Delaware limited partnership (the ?Operating Partnership?), CNI NSHC Advisors, LLC, a Delaware limited liability c
December 7, 2021	8-K	Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2021 NorthStar Healthcare Income, Inc.
December 7, 2021	EX-99.1	NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS EXHIBIT 99.1 NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Index Page Summary of Unaudited Pro Forma Consolidated Financial Statements 2 Unaudited Pro Forma Consolidated Balance Sheet as of September 30, 2021 3 Unaudited Pro Forma Consolidated Statement of Operations for the Nine Months Ended September 30, 2021 4 Unaudited Pro For
November 12, 2021	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2021 NorthStar Healthcare Income, Inc.
November 12, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of R
November 5, 2021	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2021 NorthStar Healthcare Income, Inc.
August 13, 2021	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2021 NorthStar Healthcare Income, Inc.
August 13, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Regist
July 1, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2021 NorthStar Healthcare Income, Inc.
July 1, 2021	EX-10.1	Amendment No. 3 to Advisory Agreement dated as of June 30, 2021 by and among NorthStar Healthcare Income, Inc., NorthStar Healthcare Income Operating Partnership, LP, CNI NSHC Advisors, LLC and DigitalBridge Group, Inc. (f/k/a Colony Capital, Inc.) (filed as Exhibit 10.1 to the Company's Current Report on Form 8-K filed on July 1, 2021 and incorporated herein by reference) Exhibit 10.1 EXECUTION VERSION AMENDMENT NO. 3 TO ADVISORY AGREEMENT THIS AMENDMENT NO. 3 (this ?Amendment?) is made and entered into as of June 30, 2021, and amends that certain Advisory Agreement, dated as of June 30, 2014, as amended by Amendment No. 1, dated December 20, 2017, and Amendment No. 2, dated June 22, 2020 (as amended, the ?Advisory Agreement?), by and among NorthStar Healthcare Inc
June 17, 2021	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2021 NorthStar Healthcare Income, Inc.
May 14, 2021	EX-10.1	NorthStar Healthcare Income, Inc. Fourth Amended and Restated Independent Directors Compensation Plan (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 and incorporated herein by reference) Exhibit 10.1 NORTHSTAR HEALTHCARE INCOME, INC. FOURTH AMENDED AND RESTATED INDEPENDENT DIRECTORS COMPENSATION PLAN ARTICLE 1 PURPOSE 1.1. PURPOSE. The purpose of the Plan is to attract, retain and compensate highly-qualified individuals who are not employees of NorthStar Healthcare Income, Inc. or any of its subsidiaries or affiliates for service as members of the Board by providing them with comp
May 14, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Commission File Number: 000-55190 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Empl
May 14, 2021	8-K	Regulation FD Disclosure 8-K 1 nshiq12021supplementmay2021.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2021 NorthStar Healthcare Income, Inc. (Exact name of registrant as specified in its charter) Maryland (State or other jurisdiction of
April 15, 2021	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a?6(e)(2)) x Defin
April 15, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 12, 2021 NorthStar Healthcare Income, Inc.
March 23, 2021	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2021 NorthStar Healthcare Income, Inc.
March 23, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
March 23, 2021	EX-4.2	Description of Registrant’s Securities Exhibit 4.2 Description of Registrant?s Securities References herein to ?company,? ?we,? ?us,? or ?our? refer to NorthStar Healthcare Income, Inc., a Maryland corporation, and its subsidiaries unless the context specifically requires otherwise. The following is a summary of the material terms of shares of our common stock as set forth in our charter and is qualified in its entirety by reference to
March 23, 2021	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Watermark Fountains Owner, LLC Delaware Fountains Property NT-HCI, LLC Delaware Fountains Portfolio Owner, LLC Delaware Winterfell Healthcare Holdings NT-HCI, LLC Delaware Winterfell Healthcare Own
January 27, 2021	8-K	Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2021 NorthStar Healthcare Income, Inc.
December 22, 2020	8-K	Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2020 NorthStar Healthcare Income, Inc.
November 27, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 23, 2020 NorthStar Healthcare Income, Inc.
November 13, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS
November 13, 2020	8-K	Regulation FD Disclosure - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2020 NorthStar Healthcare Income, Inc.
August 13, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Emplo
August 13, 2020	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 13, 2020 NorthStar Healthcare Income, Inc.
June 23, 2020	EX-10.1	2 to Advisory Agreement dated as of June 22, 2020 by and among NorthStar Healthcare Income, Inc., NorthStar Healthcare Income Operating Partnership, LP, CNI NSHC Advisors, LLC and Colony Capital, Inc. (f/k/a Colony NorthStar, Inc.) (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K on June 23, 2020 and incorporated herein by reference) Exhibit 10.1 AMENDMENT NO. 2 TO ADVISORY AGREEMENT THIS AMENDMENT NO. 2 (this “Amendment”) is made and entered into as of June 22, 2020, and amends that certain Advisory Agreement, dated as of June 30, 2014, as amended by Amendment No. 1, dated December 20, 2017 (as amended, the “Advisory Agreement”), by and among NorthStar Healthcare Income, Inc., a Maryland corporation (the “Company”), NorthStar
June 23, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2020 NorthStar Healthcare Income, Inc.
June 4, 2020	DEFA14A	- DEFA14A DEFA14A 1 nshidefa14a062020.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (a
May 27, 2020	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2020 NorthStar Healthcare Income, Inc.
May 8, 2020	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2020 NorthStar Healthcare Income, Inc.
May 8, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Empl
April 16, 2020	DEF 14A	NHHS / NORTHSTAR HEALTHCARE INCOME INC DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) x Defin
March 23, 2020	EX-10.7	(filed as Exhibit 10.7 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 and incorporated herein by reference) Exhibit 10.7 NORTHSTAR HEALTHCARE INCOME, INC. THIRD AMENDED AND RESTATED INDEPENDENT DIRECTORS COMPENSATION PLAN ARTICLE 1 PURPOSE 1.1. PURPOSE. The purpose of the Plan is to attract, retain and compensate highly-qualified individuals who are not employees of NorthStar Healthcare Income, Inc. or any of its subsidiaries or affiliates for service as members of the Board by providing them with compe
March 23, 2020	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
March 23, 2020	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Watermark Fountains Owner, LLC Delaware Fountains Property NT-HCI, LLC Delaware Fountains Portfolio Owner, LLC Delaware Winterfell Healthcare Holdings NT-HCI, LLC Delaware Winterfell Healthcare Own
March 23, 2020	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2020 NorthStar Healthcare Income, Inc.
March 23, 2020	EX-4.2	Description of Registrant’s Securities Exhibit 4.2 Description of Registrant’s Securities References herein to “company,” “we,” “us,” or “our” refer to NorthStar Healthcare Income, Inc., a Maryland corporation, and its subsidiaries unless the context specifically requires otherwise. The following is a summary of the material terms of shares of our common stock as set forth in our charter and is qualified in its entirety by reference to
December 9, 2019	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 3, 2019 NorthStar Healthcare Income, Inc.
December 2, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 26, 2019 NorthStar Healthcare Income, Inc.
November 14, 2019	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2019 NorthStar Healthcare Income, Inc.
November 8, 2019	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS
September 16, 2019	10-K/A	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-K/A - Annual Report - 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-
September 11, 2019	CORRESP	NHHS / NORTHSTAR HEALTHCARE INCOME INC CORRESP - - September 11, 2019 VIA OVERNIGHT DELIVERY Mr. Isaac Esquivel U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: NorthStar Healthcare Income, Inc. Form 10-K for the fiscal year ended December 31, 2018 Filed March 22, 2019 File No. 000-55190 Dear Mr. Esquivel: This letter sets forth the response of NorthStar Healthcare Income, Inc. (the
August 19, 2019	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 19, 2019 NorthStar Healthcare Income, Inc.
August 9, 2019	10-Q	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Emplo
June 21, 2019	8-K	Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders 8-K 1 nshi8-kannualmtgvotingresu.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2019 NorthStar Healthcare Income, Inc. (Exact name of registrant as specified in its charter) Maryland (State or other jurisdiction of
June 14, 2019	8-K	Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2019 NorthStar Healthcare Income, Inc.
May 10, 2019	10-Q	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-Q Quarterly Report 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Empl
April 18, 2019	DEF 14A	NHHS / NORTHSTAR HEALTHCARE INCOME INC DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) x Defin
March 22, 2019	10-K	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
March 22, 2019	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Watermark Fountains Owner, LLC Delaware Fountains Property NT-HCI, LLC Delaware Fountains Portfolio Owner, LLC Delaware Winterfell Healthcare Holdings NT-HCI, LLC Delaware Winterfell Healthcare Own
February 7, 2019	8-K	Other Events 8-K 1 nshi8-k02012019.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2019 NorthStar Healthcare Income, Inc. (Exact name of registrant as specified in its charter) Maryland (State or other jurisdiction of incorpor
December 4, 2018	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2018 NorthStar Healthcare Income, Inc.
December 4, 2018	EX-99.1	NORTHSTAR HEALTHCARE INCOME, INC. ANNOUNCES ESTIMATED VALUE OF $7.10 PER SHARE OF COMMON STOCK Exhibit 99.1 NORTHSTAR HEALTHCARE INCOME, INC. ANNOUNCES ESTIMATED VALUE OF $7.10 PER SHARE OF COMMON STOCK New York, NY, December 4, 2018 - The board of directors (the “Board”) of NorthStar Healthcare Income, Inc. (“NorthStar Healthcare” or the “Company”), a publicly registered, non-traded real estate investment trust (“REIT”) focused on a diverse portfolio of healthcare real estate investments t
November 29, 2018	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 27, 2018 NorthStar Healthcare Income, Inc.
November 13, 2018	10-Q	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS
October 12, 2018	EX-99.1	NORTHSTAR HEALTHCARE INCOME Amended Share Repurchase Program Effective October 29, 2018 Exhibit 99.1 NORTHSTAR HEALTHCARE INCOME Amended Share Repurchase Program Effective October 29, 2018 Our share repurchase program provides an opportunity for our stockholders to have their shares of common stock repurchased by us, without fees, in limited circumstances subject to certain restrictions. Beginning with repurchases made on a repurchase date (as defined below) occurring in the calendar
October 12, 2018	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2018 NorthStar Healthcare Income, Inc.
August 10, 2018	10-Q	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Emplo
June 21, 2018	8-K	Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2018 NorthStar Healthcare Income, Inc.
May 15, 2018	10-Q	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Empl
April 25, 2018	DEF 14A	NHHS / NORTHSTAR HEALTHCARE INCOME INC DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a‑6(e)(2)) x Defin
March 30, 2018	EX-21.1	Significant Subsidiaries of the Registrant Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Watermark Fountains Owner, LLC Delaware Fountains Property NT-HCI, LLC Delaware Fountains Portfolio Owner, LLC Delaware Winterfell Healthcare Holdings NT-HCI, LLC Delaware Winterfell Healthcare Own
March 30, 2018	10-K	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-K (Annual Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
December 26, 2017	EX-10.1	Amendment No. 1 to Advisory Agreement, dated as of December 20, 2017, by and among NorthStar Healthcare Income, Inc., NorthStar Healthcare Income Operating Partnership, LP, CNI NSHC Advisors, LLC and Colony NorthStar, Inc. (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 26, 2017 and incorporated herein by reference) Exhibit Exhibit 10.1 AMENDMENT NO. 1 TO ADVISORY AGREEMENT THIS AMENDMENT NO. 1 (this ? Amendment ?) is made and entered into as of December 20, 2017, and amends that certain Advisory Agreement, dated as of June 30, 2014 (the ? Advisory Agreement ?), by and among NorthStar Healthcare Income, Inc., a Maryland corporation (the ? Company ?), NorthStar Healthcare Income Operating Partnership, LP, a De
December 26, 2017	EX-99.1	NORTHSTAR HEALTHCARE INCOME Amended Share Repurchase Program Effective January 2018 Exhibit Exhibit 99.1 NORTHSTAR HEALTHCARE INCOME Amended Share Repurchase Program Effective January 2018 Our share repurchase program provides an opportunity for you to have your shares of common stock repurchased by us, without fees and subject to certain restrictions and limitations. Beginning with repurchases made in the calendar quarter ending March 31, 2018, except for shares repurchased in c
December 26, 2017	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2017 NorthStar Healthcare Income, Inc.
December 15, 2017	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 11, 2017 NorthStar Healthcare Income, Inc.
November 14, 2017	10-Q	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS
August 11, 2017	10-Q	NHHS / NORTHSTAR HEALTHCARE INCOME INC 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Emplo
August 8, 2017	8-K	Current Report Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 8, 2017 NorthStar Healthcare Income, Inc.
June 28, 2017	8-K	Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 22, 2017 NorthStar Healthcare Income, Inc.
May 12, 2017	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 Commission File Number: 000-55190 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Empl
April 28, 2017	DEF 14A	NORTHSTAR HEALTHCARE INCOME DEF 14A Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a?6(e)(2)
March 30, 2017	EX-21.1	Youâve Exceeded the SECâs Traffic Limit Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Fountains Portfolio Owner, LLC Delaware Fountains Property NT-HCI, LLC Delaware Fountains Operations NT-HCI, LLC Delaware Watermark Fountains Owner, LLC Delaware Watermark Fountains Operator, LLC D
March 30, 2017	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55190 NORTHSTAR HEAL
December 22, 2016	CORRESP	NORTHSTAR HEALTHCARE INCOME ESP Document December 22, 2016 VIA OVERNIGHT DELIVERY Ms. Sandra B. Hunter U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: NorthStar Healthcare Income, Inc. Form 10-K for the fiscal year ended December 31, 2015 Filed March 28, 2016 File No. 000-55190 Dear Ms. Hunter: This letter sets forth the response of NorthStar Healthcare Income, In
December 9, 2016	8-K	Current Report Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2016 NorthStar Healthcare Income, Inc.
November 10, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Commission File Number: 000-55 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS
August 11, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 Commission File Number: 000-55190 N UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Emplo
June 29, 2016	8-K	Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23, 2016 NorthStar Healthcare Income, Inc.
June 14, 2016	8-K	Other Events Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2016 NorthStar Healthcare Income, Inc.
May 17, 2016	EX-99.1	WINTERFELL PORTFOLIO INDEX TO THE COMBINED STATEMENT OF REVENUES AND CERTAIN OPERATING EXPENSES SEC Exhibit Exhibit 99.1 WINTERFELL PORTFOLIO INDEX TO THE COMBINED STATEMENT OF REVENUES AND CERTAIN OPERATING EXPENSES Page Report of Independent Certified Public Accountants 2 Combined Statement of Revenues and Certain Operating Expenses for the year ended December 31, 2015 3 Notes to the Combined Statement of Revenues and Certain Operating Expenses for the year ended December 31, 2015 4 1 REPO
May 17, 2016	EX-99.2	NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENT SEC Exhibit Exhibit 99.2 NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENT Page NorthStar Healthcare Income, Inc. and Subsidiaries Unaudited Pro Forma Consolidated Financial Statement 2 NorthStar Healthcare Income, Inc. and Subsidiaries Unaudited Pro Forma Consolidated Statement of Operations for the year ended December 31, 2015 3 Nort
May 17, 2016	8-K/A	Financial Statements and Exhibits SEC Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT (Amendment No.
May 13, 2016	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 Commission File Number: 000-55190 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Empl
April 27, 2016	DEF 14A	NORTHSTAR HEALTHCARE INCOME DEF 14A DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a?6(e)(2))
April 8, 2016	8-K	Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 7, 2016 NorthStar Healthcare Income, Inc.
April 8, 2016	EX-4.1	Amended and Restated Distribution Reinvestment Plan (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on April 8, 2016 and incorporated herein by reference) Exhibit Exhibit 4.1 NorthStar Healthcare Income, Inc. AMENDED AND RESTATED DISTRIBUTION REINVESTMENT PLAN This DISTRIBUTION REINVESTMENT PLAN (“Plan”) is adopted by NorthStar Healthcare Income, Inc., a Maryland corporation (the “Company”), pursuant to its charter (the “Charter”). Unless otherwise defined herein, capitalized terms shall have the same meaning as set forth in the Charter. 1. Distribu
March 28, 2016	EX-21.1	Youâve Exceeded the SECâs Traffic Limit Exhibit 21.1 NORTHSTAR HEALTHCARE INCOME, INC. List of Significant Subsidiaries Formation Entity Name Jurisdiction NorthStar Healthcare Income Operating Partnership, LP Delaware TRS NT-HCI, LLC Delaware Fountains Portfolio Owner, LLC Delaware Fountains Property NT-HCI, LLC Delaware Fountains Operations NT-HCI, LLC Delaware Watermark Fountains Owner, LLC Delaware Watermark Fountains Operator, LLC D
March 28, 2016	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K 10-K 1 nshi1231201510-k.htm 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File
March 8, 2016	EX-24	POWER OF ATTORNEY Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that the undersigned hereby constitutes, designates and appoints Daniel R.
March 8, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2016 NorthStar Healthcare Income, Inc.
March 1, 2016	EX-10.1	Purchase and Sale Agreement Regarding Interests in Limited Liability Companies, dated as of February 24, 2016, by and between Winterfell Healthcare Holdings - T, LLC, Winterfell Healthcare-T CAM2, LLC and Winterfell Healthcare Holdings - NT-HCI, LLC and Winterfell Healthcare NT-HCI CAM2, LLC (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 1, 2016 and incorporated herein by reference) Exhibit Exhibit 10.1 PURCHASE AND SALE AGREEMENT REGARDING INTERESTS IN LIMITED LIABILITY COMPANIES THIS PURCHASE AND SALE AGREEMENT REGARDING INTERESTS IN LIMITED LIABILITY COMPANIES (this ? Agreement ?) is made as of February 24, 2016 (the ? Effective Date ?), by and between WINTERFELL HEALTHCARE HOLDINGS-T, LLC (? Owner Seller ?) and WINTERFELL HEALTHCARE-T CAM2, LLC (? Manager Seller ?), each
March 1, 2016	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2016 NorthStar Healthcare Income, Inc.
February 12, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2016 NorthStar Healthcare Income, Inc.
December 8, 2015	S-3D	NORTHSTAR HEALTHCARE INCOME S-3D S-3D As filed with the Securities and Exchange Commission on December 7, 2015 Registration No.
December 2, 2015	8-K	Completion of Acquisition or Disposition of Assets 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2015 NorthStar Healthcare Income, Inc.
December 2, 2015	424B3	NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 14 DATED DECEMBER 2, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 424B3 1 nshi-supplementno14triliog.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-199125 NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 14 DATED DECEMBER 2, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 This Supplement No. 14 supplements, and should be read in conjunction with, our prospectus dated February 6, 2015, as supplemented by Supplement No. 11 dated August 19, 2015, Sup
November 13, 2015	424B3	NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 13 DATED NOVEMBER 12, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 10-Q Filed Pursuant to Rule 424(b)(3) Registration No. 333-199125 NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 13 DATED NOVEMBER 12, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 This Supplement No. 13 supplements, and should be read in conjunction with, our prospectus dated February 6, 2015, as supplemented by Supplement No. 11 dated August 19, 2015 and Supplement No. 12 dated September 14, 2
November 12, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Commission File Number: 000-55 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS
September 15, 2015	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2015 NorthStar Health UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 11, 2015 NorthStar Healthcare Income, Inc.
September 15, 2015	424B3	NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 12 DATED SEPTEMBER 14, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-199125 NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 12 DATED SEPTEMBER 14, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 This Supplement No. 12 supplements, and should be read in conjunction with, our prospectus dated February 6, 2015, as supplemented by Supplement No. 11 dated August 19, 2015. Defined terms used in this Supplement No
September 15, 2015	EX-10.1	EQUITY PURCHASE AGREEMENT by and among TRILOGY INVESTORS, LLC, TRILOGY HOLDINGS LP, TRILOGY HOLDINGS LLC, TRILOGY HOLDINGS CORPORATION, THE SELLERS IDENTIFIED HEREIN TRILOGY REAL ESTATE INVESTMENT TRUST September 11, 2015 EXHIBIT 10.1 EQUITY PURCHASE AGREEMENT by and among TRILOGY INVESTORS, LLC, TRILOGY HOLDINGS LP, TRILOGY HOLDINGS LLC, TRILOGY HOLDINGS CORPORATION, THE SELLERS IDENTIFIED HEREIN and TRILOGY REAL ESTATE INVESTMENT TRUST September 11, 2015 TABLE OF CONTENTS Page ARTICLE I PURCHASE AND SALE OF THE SECURITIES 2 1.01 Pre-Closing Reorganization 2 1.02 Basic Transactions 4 1.03 Total Equity Value; Alloc
September 15, 2015	EX-10.2	Limited Liability Company Agreement of Trilogy REIT Holdings, LLC, dated as of September 11, 2015, by and between GACH3 Trilogy JV, LLC and Trilogy Holdings NT-HCI, LLC (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on September 15, 2015 and incorporated herein by reference) EXHIBIT 10.2 LIMITED LIABILITY COMPANY AGREEMENT OF TRILOGY REIT HOLDINGS, LLC (A Delaware limited liability company) Dated as of September 11, 2015 The membership interests evidenced hereby have not been registered with the Securities and Exchange Commission under the Securities Act (as defined herein) in reliance upon an exemption from registration thereunder and have not been registered or qual
September 1, 2015	424B3	NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 11 DATED AUGUST 19, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-199125 NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 11 DATED AUGUST 19, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 This Supplement No. 11 supplements, and should be read in conjunction with, our prospectus dated February 6, 2015 and the additional information incorporated by reference herein and described under the heading ?Incorpo
August 21, 2015	EX-24	POWER OF ATTORNEY Exhibit 24 POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS that the undersigned hereby constitutes, designates and appoints Daniel R.
August 19, 2015	POS AM	As filed with the Securities and Exchange Commission on August 19, 2015 As filed with the Securities and Exchange Commission on August 19, 2015 Registration No.
August 14, 2015	EX-99.1	FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Consolidated Financial Statements December 31, 2014 (With Independent Auditors’ Report Thereon) FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Table of Contents EX-99.1 2 exhibit991fountains1231201.htm EXHIBIT 99.1 Exhibit 99.1 FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Consolidated Financial Statements December 31, 2014 (With Independent Auditors’ Report Thereon) FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Table of Contents Page(s) Independent Auditors’ Report 1 Consolidated Financial Statements as of and for the year ended Decembe
August 14, 2015	EX-99.2	FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Unaudited condensed consolidated financial statements For the Three Months Ended March 31, 2015 and 2014 FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Table of Contents Page(s) Condensed Exhibit Exhibit 99.2 FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Unaudited condensed consolidated financial statements For the Three Months Ended March 31, 2015 and 2014 FOUNTAINS SENIOR LIVING HOLDINGS, LLC AND SUBSIDIARIES Table of Contents Page(s) Condensed consolidated financial statements as of March 31, 2015 (unaudited) and December 31, 2014 and for the three months ended March 31
August 14, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission File Number: 000-55190 N UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Commission File Number: 000-55190 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland 27-3663988 (State or Other Jurisdiction of (IRS Emplo
August 14, 2015	8-K/A	Financial Statements and Exhibits 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2015 NORTHSTAR HEALTHCARE INCOME, INC. (Exact Name of Registrant as Specified in its Charter) Maryland (State or Other Jurisdiction of Incorporation or
August 14, 2015	424B3	NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 10 DATED AUGUST 14, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-199125 NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 10 DATED AUGUST 14, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 This Supplement No. 10 supplements, and should be read in conjunction with, our prospectus dated February 6, 2015, as supplemented by Supplement No. 1 dated February 25, 2015, Supplement No. 2 dated March 27, 2015, Sup
August 14, 2015	EX-10.7	PURCHASE AND SALE AGREEMENT EACH PARTY LISTED AS A “SELLER” ON SCHEDULE I AS SELLER WINTERFELL HEALTHCARE HOLDINGS – T, LLC WINTERFELL HEALTHCARE HOLDINGS – NT-HCI, LLC AS PURCHASER TABLE OF CONTENTS Page ARTICLE I DEFINED TERMS 1 ARTICLE II PURCHASE Exhibit 10.7 PURCHASE AND SALE AGREEMENT BETWEEN EACH PARTY LISTED AS A ?SELLER? ON SCHEDULE I AS SELLER AND WINTERFELL HEALTHCARE HOLDINGS ? T, LLC AND WINTERFELL HEALTHCARE HOLDINGS ? NT-HCI, LLC AS PURCHASER TABLE OF CONTENTS Page ARTICLE I DEFINED TERMS 1 ARTICLE II PURCHASE AND SALE, PURCHASE PRICE AND DEPOSIT 1 2.1 Purchase and Sale 1 2.2 Purchase Price and Deposit 2 2.3 Escrow Provisions Re
August 14, 2015	EX-99.3	NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO PRO FORMA FINANCIAL STATEMENTS Exhibit Exhibit 99.3 NORTHSTAR HEALTHCARE INCOME, INC. AND SUBSIDIARIES INDEX TO PRO FORMA FINANCIAL STATEMENTS NorthStar Healthcare Income, Inc. and Subsidiaries Unaudited Pro Forma Condensed Consolidated Financial Information 2 NorthStar Healthcare Income, Inc. and Subsidiaries Unaudited Pro Forma Condensed Consolidated Statement of Operations for the three months ended March 31, 2015 3 NorthSta
July 8, 2015	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets NSHI - 8-K (Espresso Closing 7.1.2015) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2015 NorthStar Healthcare Income, Inc. (Exact name of registrant as specified in its charter) Maryland (State or other jurisdiction of inc
July 8, 2015	424B3	NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 9 DATED JULY 8, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 NHI Supplement No. 9 - Espresso Filed Pursuant to Rule 424(b)(3) Registration No. 333-199125 NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 9 DATED JULY 8, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 This Supplement No. 9 supplements, and should be read in conjunction with, our prospectus dated February 6, 2015, as supplemented by Supplement No. 1 dated February 25, 2015, Supplement No. 2 date
July 8, 2015	EX-10.1	Joint Venture Governing Documents, each dated as of July 1, 2015, by and among FC Domino Investors, LLC, Domino MI6 Investors, LLC, Domino Holdings NT-HCI, LLC, FC Domino General Partner, LLC, SSCIP VI Splitter, LP, SSCIP VI SLP, LLC, FC SLP VI, LLC, Formation Capital Asset Management III, LLC and Safanad SSCIP VI Management, LLC, as applicable (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 8, 2015 and incorporated herein by reference) NSHI - 8-K (Espresso 7.1.2015) EX 10.1 Exhibit 10.1 Execution Copy AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF FC DOMINO INVESTORS, LLC Dated as of July 1, 2015 1160165.07-NYCSR03A - MSW TABLE OF CONTENTS Page Article 1. DEFINITIONS 2 1.01. Defined Terms 2 1.02. Interpretation 12 Article 2. FILING; NAME; PLACE OF BUSINESS 12 2.01. Filing 12 2.02. Name of Venture 12 2.03. Place of B
July 1, 2015	424B3	NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 8 DATED JULY 1, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 424B3 1 nshisupplementno8annualmtg.htm 424B3 Filed Pursuant to Rule 424(b)(3) Registration No. 333-199125 NORTHSTAR HEALTHCARE INCOME, INC. SUPPLEMENT NO. 8 DATED JULY 1, 2015 TO THE PROSPECTUS DATED FEBRUARY 6, 2015 This Supplement No. 8 supplements, and should be read in conjunction with, our prospectus dated February 6, 2015, as supplemented by Supplement No. 1 dated February 25, 2015, Suppleme
July 1, 2015	8-K	Entry into a Material Definitive Agreement, Other Events, Submission of Matters to a Vote of Security Holders NSHI - 8-K (Annual Mtg/Advisory Renewal/SRP) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2015 NorthStar Healthcare Income, Inc.
June 5, 2015	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets NSHI - 8-K (Fountains Closing 6.1.2015) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2015 NorthStar Healthcare Income, Inc. (Exact name of registrant as specified in its charter) Maryland (State or other jurisdiction of in
June 5, 2015	EX-10.1	PARTIAL ASSIGNMENT AND ASSUMPTION OF, AND FIFTH AMENDMENT TO, PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS NSHI - 8-K (Fountains 6.1.2015) EX 10.1 Exhibit 10.1 PARTIAL ASSIGNMENT AND ASSUMPTION OF, AND FIFTH AMENDMENT TO, PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS THIS PARTIAL ASSIGNMENT AND ASSUMPTION OF, AND FIFTH AMENDMENT TO PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (this ? Amendment ? or the ? Fifth Amendment ?) is made as of this 1st day of June, 2015, by and among

NHHS / NorthStar Healthcare Income, Inc. - Depositi SEC, Relazione annuale, dichiarazione di delega

Statistiche di base

SEC Filings

SEC Filings (Chronological Order)